<DOC>
	<DOCNO>NCT02252757</DOCNO>
	<brief_summary>Heart failure common cardiovascular problem increase prevalence incidence associate substantial morbidity mortality . The management heart failure patient complex become priority world . Effective method keep heart failure patient hospital essential , interest patient 's health , well reduce burden health care system</brief_summary>
	<brief_title>Assess Measurements Wireless Cardiac Output Device</brief_title>
	<detailed_description>Heart failure patient position provide reading weight , blood pressure , fluid intake , thoracic fluid , heart rate , heart rate variability , respiration rate , stroke volume , cardiac output , medication important parameter communicate data care provider use wireless technology . This data make available medical personnel regularly periodic basis . In manner health care provider detect respond warning sign alert patient 's condition worsen warrant visit doctor hospital admission feature heart failure decompensation . Programs chronic heart failure include remote monitor show positive effect clinical outcome community dwell patient chronic heart failure . In preparation study evaluate effectiveness mobile monitoring , value Stroke Volume Cardiac Output need validated FDA approve device available hospital clinic setting . This study cover validation measurement take propose home monitoring device , Perminova 's CoVaTM Sensor ( Sensor ) clinic device bio-impedance device , echocardiogram , Doppler and/or MRI</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subjects either gender age 18 year The subject able willing provide write informed consent prior enrollment study One follow diagnosis New York Heart Association ( NYHA ) classification class IIV Stages AD Symptoms dyspnea Chronic renal failure renal replacement therapy Patients may come follow likely drop study Any illness may preclude regular follow Patient unable willing wear electrode patch require Patient skin sensitivity adhesive hydrogel material use electrode patch Patient consider PI medically unsuitable study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>mHealth , hypertension , atherosclerotic disease , diabetes , obesity , metabolic syndrome , cardiotoxins , cardiomyopathy , dsypnea</keyword>
</DOC>